Using Early Drug Development Decisions to Facilitate and Accelerate Device Development Strategies

27 September 2022 12:15 - 12:45

Too often the development of the device constituent of a combination product continues to be reactive to the drug development deadlines.

This case study presentation will focus on how decisions early in the drug development program can be leveraged for creation of the device strategy, timely execution of selected strategy and earlier insights of risks to timelines, safety and cost.

Jerzy Wojcik, VP Regulatory and Quality Services, EdgeOne Medical Inc